Related Experiment Video
Updated: Jul 5, 2026
13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
Male breast cancer: 6-year experience
M La Pinta1, A Fabi, A Ascarelli
1Breast Unit, San Giovanni-Addolorata Hospital, Rome. mlapinta68@hotmail.com
Minerva Chirurgica
|April 23, 2008
Summary
Male breast cancer is rare, but prognosis is similar to females when diagnosed at the same stage. Surgical treatment is standard, with adjuvant therapies guided by female breast cancer protocols.
Area of Science:
- Oncology
- Male Breast Cancer Research
Background:
- Male breast cancer is a rare malignancy, representing 1% of all breast cancers and 1% of male malignancies.
- The incidence ratio is approximately 1:100 (men to women).
Purpose of the Study:
- To characterize male breast cancer regarding epidemiology, diagnosis, prognosis, treatment, and survival.
- To review the literature and present case series data.
Main Methods:
- Literature review.
- Retrospective analysis of 4 male breast cancer cases treated at a single Breast Unit.
Main Results:
- All 4 tumors were ductal carcinomas.
- Stage distribution: 3 Stage I, 1 Stage IIIB.
- Estrogen and progesterone receptor expression varied (20-100%).
- Median follow-up was 57.5 months. Stage I patients showed good outcomes; the Stage IIIB patient died from metastatic disease.
Conclusions:
- Surgical treatment is the primary approach for male breast cancer.
- Prognosis in males is comparable to females at equivalent disease stages.
- Adjuvant therapy follows guidelines established for female breast cancer based on retrospective data.
